Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› İzmit
Clinical trial register · Turkey

Clinical Trials in İzmit, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 1988 Ankara 1440 Izmir 568 Adana 377 Antalya 261
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sanofi7 AstraZeneca6 Hoffmann-La Roche4 Eli Lilly and Company4 Kocaeli University3
Site location
Istanbul1988 Ankara1440 Izmir568 Adana377 Antalya261
All 318 locations
Target enrolment
to

Trials with a site in İzmit

49 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Not yet open
Halic University
Observational
45
İzmit
2026-09-03
Recruiting
AstraZeneca
Phase 3
2,800
Adapazarı, Ankara, Antalya, Dinar, İzmit, Kahramanmaraş, Kayseri, Kazımkarabekir
2026-09-01
Recruiting
Engin Çetin
Not applicable
90
İzmit
2026-07-01
Recruiting
POCD After Major Gynecologic Surgery
NCT07589348Postoperative Cognitive Dysfunction, Perioperative Neurocognitive Disorder
Fatihhan Zeytun
Observational
72
İzmit
2026-05-06
Recruiting
Engin Çetin
Not applicable
54
İzmit
2026-05-01
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Adana, Ankara, Antalya, Bornova, Hatay, Istanbul, İzmit, Mersin
2026-03-26
Recruiting
Boehringer Ingelheim
Phase 2
132
Adana, Ankara, Bursa, Istanbul, İzmit, Melikgazi/Kayseri
2026-03-23
Recruiting
Comparison of Awake Tracheal Intubation Methods
NCT07484841Airway Management Assessment, Awake Endotracheal Intubation, Awake Fiberoptic Nasal Intubation, Videolaryngoscopy
Kocaeli City Hospital
Not applicable
201
İzmit
2026-03-20
Recruiting
Boehringer Ingelheim
Phase 3
286
Adana, Ankara, Battalgazi / Malatya, Bursa, Istanbul, İzmit, Melikgazi/Kayseri, Merkez / Afyonkarahisar
2026-02-16
Recruiting
Eli Lilly and Company
Phase 2
252
Adana, Ankara, Antalya, Eskişehir, Hatay, İzmit, Malatya, Mersin
2025-11-10
Recruiting
Tulip Airway in Difficult Mask Ventilation (TADMV)
NCT07204223Difficult Mask Ventilation, Airway Devices
Ayse Zeynep Turan Civraz
Not applicable
30
İzmit
2025-10-01
Recruiting
Kocaeli University
Not applicable
90
İzmit
2025-09-01
Recruiting
Celcuity Inc
Phase 3
1,180
Adana, Ankara, Diyarbakır, Edirne, Istanbul, İzmit, Konya, Mezitli
2025-07-24
Recruiting
AstraZeneca
Phase 2
987
Adana, Ankara, Bursa, İzmit, Kayseri, Mersin
2025-06-27
Recruiting
Eli Lilly and Company
Phase 3
290
Ankara, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit, Mersin
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Ankara, Antalya, Bursa, Eskişehir, Hatay, Istanbul, Izmir, İzmit
2025-06-26
Recruiting
GlaxoSmithKline
Phase 3
981
Izmir, Antalya, Denizli, Çanakkale, İzmit
2025-06-20
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Adana, Afyonkarahisar, Ankara, Izmir, İzmit
2025-06-10
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Istanbul, Izmir, İzmit, Mersin, Sakarya, Sanliurfa, Trabzon
2025-05-27
Recruiting
Biogen
Phase 3
454
İzmit, Ankara, Istanbul, Sanliurfa, Antalya, Kayseri, Konya
2025-05-08
Recruiting
AstraZeneca
Phase 3
830
Ankara, Bakırköy, Çankaya, İzmit, Küçükçekmece, Yüreğir
2025-04-10
Recruiting
Summit Therapeutics
Phase 3
780
Istanbul, Ankara, Adana, Antalya, Diyarbakır, Gaziantep, Izmir, İzmit
2025-02-27
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Adapazarı, Ankara, Antalya, Istanbul, Izmir, İzmit, Mersin, Samsun
2025-01-03
Recruiting
Sanofi
Phase 2
84
İzmit, Kayseri
2024-12-19
Recruiting
Kocaeli University
Not applicable
60
İzmit, Kocaeli
2024-10-24
By invitation
Sanofi
Phase 2
900
Bursa, Istanbul, İzmit, Kayseri, Kirikkale, Mersin
2024-09-30
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
Adana, Sakarya, Ankara, Kadıköy, Istanbul, Balçova, İzmit, Konya
2024-09-27
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Ankara, Antalya, Izmir, İzmit, Malatya
2024-08-28
Active, closed
Kocaeli University
Observational
55
İzmit
2024-07-29
Recruiting
CSL Behring
Phase 2/3
3,110
Ankara, Antalya, Atakum, Bakırköy, Bornova, Edirne, Gaziantep, İzmit
2024-04-27
Active, closed
Samsung Bioepis Co., Ltd.
Phase 3
555
Adapazarı, Ankara, Bağcılar, Balgat, Çubuk, Istanbul, İzmit, Kavaklıdere
2024-03-12
Recruiting
Arch Biopartners Inc.
Phase 2
240
Yenimahalle, Kartal, Melikgazi, İzmit, Kahramanmaraş
2024-03-08
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
100
Ankara, Istanbul, İzmit, Kayseri, Manisa
2024-01-16
Active, closed
Sanofi
Phase 3
943
Ankara, Bursa, Eskişehir, Istanbul, Izmir, İzmit, Kayseri, Konya
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Ankara, Bursa, Eskişehir, Istanbul, Izmir, İzmit, Kayseri, Konya
2023-12-13
Recruiting
LeonaBio
Phase 3
600
Çankaya, Çapa, Kadiköy, Bornova, Konak, İzmit, Ankara, Bursa
2023-10-31
Active, closed
Summit Therapeutics
Phase 3
1,600
Sur, Bornova, İzmit, Meram, Ankara, Gaziantep, Istanbul, Izmir
2023-10-26
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Ankara, Istanbul, İzmit
2023-09-18
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Bornova, İzmit, Antalya, Kayseri
2023-07-06
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Yüreğir, Sur, İzmit, Gaziantep, Ankara, Edirne, Istanbul
2023-01-16
Recruiting
AstraZeneca
Phase 3
3,527
Ankara, Diyarbakır, Istanbul, Izmir, İzmit, Malatya, Ortahisar
2022-12-13
Active, closed
Hoffmann-La Roche
Phase 3
922
Adana, Ankara, Diyarbakır, Edirne, Erzurum, Istanbul, Izmir, İzmit
2022-07-18
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Yüreğir, Istanbul, Izmir, İzmit, Gaziantep, Ankara, Diyarbakır, Edirne
2022-07-14
Active, closed
Sanofi
Phase 3
104
Ankara, Istanbul, İzmit
2022-05-03
Active, closed
Sanofi
Phase 3
122
Ankara, İzmit, Malatya
2022-03-11
Active, closed
Hoffmann-La Roche
Phase 3
660
Ankara, Bursa, Denizli, Diyarbakır, Edirne, Istanbul, Izmir, İzmit
2021-11-18
Active, closed
Sanofi
Phase 2
129
Eskişehir, Istanbul, İzmit, Mersin
2021-06-07
Active, closed
Incyte Corporation
Phase 3
899
Ankara, Izmir, İzmit, Malatya, Mersin
2021-05-11
Active, closed
Hoffmann-La Roche
Phase 3
992
Ankara, Edirne, Istanbul, Izmir, İzmit, Malatya, Samsun
2020-10-09
Rows per page Showing 1–49 of 49
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/zmit

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 49 of those studies with a site in İzmit.

How many clinical trials are recruiting in İzmit?

29 of the 49 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 18 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (İzmit), 49 studies
PhaseStudiesRecruitingShare
Phase 3281357.1%
Phase 211822.4%
Not applicable6612.2%
Observational316.1%
Phase 2/3112%

Most active sponsors

Lead sponsors with the most studies (İzmit)
Lead sponsorStudiesRecruiting
Sanofi71
AstraZeneca64
Eli Lilly and Company44
Hoffmann-La Roche40
Kocaeli University32
Boehringer Ingelheim22
Engin Çetin22
Regeneron Pharmaceuticals20
Summit Therapeutics21
Arch Biopartners Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.